Categories
Activities

February 2018 Technologies Wanted

Innovation Gateway occasionally receives requests from companies seeking solutions to product development challenges and expressing interest in new research tools that may be used in research relating to human, veterinary and plant diseases (broadly defined).

Do you have any materials in your labs that fit the bill?

Innovation Gateway occasionally receives requests from companies seeking solutions to product development challenges and expressing interest in new research tools that may be used in research relating to human, veterinary and plant diseases (broadly defined). If you have solutions to these needs or have any unique research tools, please contact us at gateway@uga.edu.

  • Ongoing research and/or existing developments in the area of quantum materials as new paths/materials to realizing innovative optoelectronic components (ELQ-LED). Ideally, materials and/or solutions being contemplated will be free of cadmium.
  • Novel therapies are sought for compounds active against Neisseria gonorrhoeae, which has developed a broad spectrum of antibiotic resistance. A minimum of in vitro data showing efficacy is needed. While studies involving animal models are not required for submitting an invention disclosure to Innovation Gateway, this additional data would be advantageous.
  • Compounds active against Yersinia pestis. These can be novel compounds or compounds approved for other diseases and that can be repurposed as therapeutics against Y. pestis. Both small- and large-molecule compounds are of interest, provided that at least in vitro data is available.
  • Any research tools (compounds, antibodies, proteins, etc.) that can be used in the field of neurology and for which this use has been published in a journal or thesis/dissertation.
  • Published Mono- and polyclonal antibodies against the following (please, provide citations):
    • Yersinia pestis
    • Neisseria gonorrhoeae
    • Treponema pallidum
    • Chlamydia trachomatis
    • Trichomonas vaginalis
    • Tau (τ) proteins
    • Amyloid Beta 42 Peptide
    • Ebola
    • Yellow fever
    • Dengue virus
    • Chikungunya virus
    • Hep C virus
    • Other viruses (human, animal or plant pathogen)
  • Low Cost Resin or Fillers for Thinwall Injection Molding
    • Cost-effective, commercial-ready material replacement to low-density polyethylene (LDPE) that can run in existing injection molds or low cost fillers that can be added to LDPE as blend to yield savings in the molded part. For example, polypropylene [PP] may be lower cost and would be of interest if it can meet our material property requirements (specified above) and is compatible with the existing injection molds.
    • Low cost fillers that are compatible with high speed injection molding processing without the abrasion seen with calcium carbonate and other materials.
    • Material with lesser environmental footprint, so more sustainable.
    • Material/components with supply base in North America and Europe.
  • Non-Toxic Insect Attractant
    • Insect-attractant technologies that are non-toxic to people and pets, and that are effective toward at least one of the following: House Flies, Mosquitoes, Fruit Flies, Stink Bugs, Bed Bugs, Roaches, Ants, Moths, and Gnats.
  • Products/Technologies for Caregiving of the Elderly
    • Products or technologies shown to address the needs of both 65+ aging at home and those caring for them.
    • Disruptive solutions that address some of the biggest challenges in the caregiving journey.
    • Solutions that help orienting & navigating both the caregiver and the care receiver through the aging journey.
    • In-home monitoring & prevention of events that result in hospital visits, including mobility and fall prevention.
    • Activities of Daily Living, including showering/bathing (including solutions that mimic the showering/bathing experience), toileting, incontinence care, and personal hygiene.
    • Skin health management solutions for the aging skin.
  • Products/Technologies for Alleviating Menopause Symptoms
    • Products or technologies shown to address the symptoms of menopause without a prescription. Solutions must enable unique benefits/claims or superior performance vs. available solutions in the menopause space, preferably the following but not required:
      • Non-estrogenic – technologies that don’t activate estrogen receptors (i.e. not estrogen mimics).
      • Naturally based technologies with peer-reviewed scientific evidence – e.g. sourced from botanicals, food sources, traditional medicine, etc.
      • Non-GMO approaches to increase function/activity of biologicals (e.g. probiotics, botanicals).
      • Novel ingredient delivery approaches.
  • Oral Care – Novel Cleaning Agents
    • GRAS (Generally Recognized As Safe) compounds and mixtures such as food grade ingredients.
    • Minimizes the deposition, growth or maturation of plaque, ideally without mechanical removal forces.
  • Vitamins Minerals Supplements
    • Technologies capable of providing new or augmenting established health claims, increasing consumer satisfaction, enhancing consumer compliance, or enabling greater convenience. Opportunities may consist of new product forms, packaging innovations, delivery technologies, or new ingredients or ingredients’ combinations. We are looking for opportunities that are in-market, market-ready, or require limited development. Not of interest: products that would require commercialization as a pharmaceutical or that would require FDA approval.

Contact Innovation Gateway (gateway@uga.edu) if you have such tools or would like to learn more about this and other opportunities relating to research tools.